BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Medical Diagnostic

Gene Solutions Achieves Landmark Validation for Asia’s First Clinically Proven Multi-Cancer Blood Test, SPOT-MAS

Gene Solutions, a leading biotech company in Asia, proudly announces a groundbreaking achievement in cancer early detection. Common cance...

March 27, 2025 | News

Shanghai ArkBio Completes Phase III Trial of AK0901 for Pediatric ADHD in China

Shanghai Ark Biopharmaceutical Co., Ltd. announced the successful completion of the Phase III clinical study of AK0901, a novel drug for the treatment of a...

March 25, 2025 | News

GSK’s Omjjara Receives Local Approval in Singapore for Myelofibrosis Patients with Moderate to Severe Anaemia

Approval is for use in myelofibrosis patients with moderate to severe anaemia who are JAK-naive or previously treated with ruxolitinib Nearly all myelof...

March 25, 2025 | News

Alamar Biosciences Launches NULISAseq Mouse Panel 120 to Power Precision Biomarker Discovery in Preclinical Research

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the launch of the NULISAseq M...

March 26, 2025 | News

Telix Secures FDA Approval for Gozellix® to Expand PSMA-PET Imaging Access in Prostate Cancer

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administrat...

March 21, 2025 | News

Vatech and Pearl Partner to Elevate Dental AI Diagnostics with Seamless Integration

Vatech, a global leader in dental imaging solutions, and Pearl, a frontrunner in dental AI technology, have announced a collaborative alliance aimed at tra...

March 19, 2025 | News

Lunit Secures Multi-Year AI Partnership with SEHA to Advance Breast Cancer Screening in UAE

Lunit , a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced that it has signed a multi-year contract with Abu Dha...

March 19, 2025 | News

Akeso’s Penpulimab Secures NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer

Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National ...

March 18, 2025 | News

VISTA Eye Specialist Advances Cataract Surgery in Malaysia with AI and Leading Ophthalmic Technologies

Klinik Pakar Mata VISTA Eye Specialist (VISTA), a well-established name in eye care in Malaysia, continues to improve its cataract surg...

March 17, 2025 | News

C2N Diagnostics Secures $10M Investment from Samsung to Expand Alzheimer’s Blood Biomarker Testing

-C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, announced a $...

March 14, 2025 | News

AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia

Chronic kidney disease (CKD) is a growing public health challenge in Asia, affecting over 400 million people. In an insightful discussion with BioPharma AP...

March 12, 2025 | News

Gleneagles Hospital Hong Kong Becomes Asia’s First Private Hospital to Offer Histotripsy for Liver Cancer Treatment

Gleneagles Hospital Hong Kong (Gleneagles) is excited to be the first private hospital in Asia to offer Histotripsy treatment, the transformative...

March 11, 2025 | News

South Korea’s Lunit AI Proven to Enhance Breast Cancer Detection in Landmark Multicenter Study

Lunit, a global leader in AI-powered cancer diagnostics, has announced groundbreaking results from the world’s first large-scale, multicenter, prospe...

March 11, 2025 | News

Docquity Partners with RSUD Umar Wirahadikusumah Sumedang to Enhance Healthcare with AI-Powered Medical Resource Platform Dx

Dx, Docquity's AI platform which is in ongoing development, will enable physicians at the Sumedang hospital to securely access the latest medical re...

March 07, 2025 | News

Stay Connected